Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin vs Sodium Bicarbonate Catheter Lock Solutions in Hemodialysis
NCT04772209Completed
- Sponsor
- Zonguldak Atatürk State Hospital
- Start
- Feb 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sodium bicarbonate in catheter occlusion and Catheter-related infection (CRI) (2 arms), sponsored by Zonguldak Atatürk State Hospital. Primary endpoints: Time to first catheter failure at 6 months, Total Duration of catheter usage at 6 months and 4 more. Started Feb 2021; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
catheter occlusionCatheter-related infection (CRI)
Beyond the preview
Go deeper on NCT04772209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04772209.